Nucleus was the original Sonata client who drove all the UK growth. Them moving to FNZ is a clear indication that BVS have not invested sufficiently into R&D. This is always the risk with a fintech that pays dividends. They serve two masters which rarely ends well.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.26 |
Change
0.040(1.80%) |
Mkt cap ! $1.017B | |||
| Open | High | Low | Value | Volume |
| $2.21 | $2.27 | $2.20 | $513.4K | 229.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 15653 | $2.26 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.27 | 14299 | 15 |
View Market Depth
| Last trade - 11.25am 27/06/2025 (20 minute delay) ? |
| BVS (ASX) Chart |